In 2016 , NAT won their case in the High Court .
In 2016 , NAT won a later appeal , resulting in the IMPACT trial , which will benefit at least 10,000 at - risk patients in England .
In 2016 , NAT won their case in the High Court and won a later appeal , resulting in the IMPACT trial , which will benefit at least 10,000 at - risk patients in England .